Protalix BioTherapeutics, Inc. (FRA:PBDA)
Germany · Delayed Price · Currency is EUR 1.930
+0.210 (12.21%)
At close: Jan 30, 2026
Protalix BioTherapeutics Market Cap
Protalix BioTherapeutics has a market cap or net worth of €158.4 million as of January 30, 2026. Its market cap has increased by 2.00% in one year.
Market Cap
158.40M
Enterprise Value
140.56M
Revenue
52.71M
Ranking
n/a
PE Ratio
34.45
Stock Price
€1.93
Market Cap Chart
Since January 3, 2007, Protalix BioTherapeutics's market cap has increased from 6.34M to 158.40M, an increase of 2,397.01%. That is a compound annual growth rate of 18.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 158.40M | 28.47% |
| Dec 31, 2025 | 123.29M | -7.79% |
| Dec 31, 2024 | 133.71M | 13.82% |
| Dec 29, 2023 | 117.48M | 80.88% |
| Dec 30, 2022 | 64.95M | 94.95% |
| Dec 31, 2021 | 33.32M | -65.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Allane SE | 204.05M |
| Eleving Group | 186.27M |
| ADM Hamburg Aktiengesellschaft | 173.72M |
| Deutsche Real Estate AG | 172.89M |
| 029 Group SE | 156.00M |
| Greenland Resources | 151.41M |
| LEWAG Holding Aktiengesellschaft | 136.86M |
| Mineralbrunnen Überkingen-Teinach GmbH & Co. KGaA | 129.61M |